Selected research
Market Analysis & Forecast
Global Environmental Legionella Pneumophila Testing Market Analysis and Forecast 2026-2032
Market perspective
The global Environmental Legionella Pneumophila Testing market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Environmental Legionella Pneumophila Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Environmental Legionella Pneumophila Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Environmental Legionella Pneumophila Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Environmental Legionella Pneumophila Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Environmental Legionella Pneumophila Testing include Abbott Laboratories, AEMTEK, ALS Environmental, BD, BioMérieux, Bio-Rad Laboratories, Eiken Chemical, Eurofins Scientific and HP Environmental, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Environmental Legionella Pneumophila Testing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Environmental Legionella Pneumophila Testing, also provides the revenue of main regions and countries. Of the upcoming market potential for Environmental Legionella Pneumophila Testing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Environmental Legionella Pneumophila Testing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Environmental Legionella Pneumophila Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Environmental Legionella Pneumophila Testing revenue, projected growth trends, production technology, application and end-user industry.
Environmental Legionella Pneumophila Testing Segment by Company
Abbott Laboratories
AEMTEK
ALS Environmental
BD
BioMérieux
Bio-Rad Laboratories
Eiken Chemical
Eurofins Scientific
HP Environmental
Intertek
Merck KGaA
Nova Biologicals
QuidelOrtho
SGS S.A.
TÜV Nord
Thermo Fisher Scientific
Environmental Legionella Pneumophila Testing Segment by Type
Urine Antigen Test (UAT)
Immunofluorescence Assay (Direct and Indirect)
Polymerase Chain Reaction (PCR)
Other
Environmental Legionella Pneumophila Testing Segment by Application
Hospitals and Cinics
Diagnostic Laboratories
Environmental Legionella Pneumophila Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Environmental Legionella Pneumophila Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Environmental Legionella Pneumophila Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Environmental Legionella Pneumophila Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Environmental Legionella Pneumophila Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Environmental Legionella Pneumophila Testing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Environmental Legionella Pneumophila Testing revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Urine Antigen Test (UAT)
- Immunofluorescence Assay (Direct and Indirect)
- Polymerase Chain Reaction (PCR)
- Other
Applications
- Hospitals and Cinics
- Diagnostic Laboratories
Companies covered
- Abbott Laboratories
- AEMTEK
- ALS Environmental
- BD
- BioMérieux
- Bio-Rad Laboratories
- Eiken Chemical
- Eurofins Scientific
- HP Environmental
- Intertek
- Merck KGaA
- Nova Biologicals
- QuidelOrtho
- SGS S.A.
- TÜV Nord
- Thermo Fisher Scientific
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Environmental Legionella Pneumophila Testing Market by Type
- 1.2.1 Global Environmental Legionella Pneumophila Testing Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Urine Antigen Test (UAT)
- 1.2.3 Immunofluorescence Assay (Direct and Indirect)
- 1.2.4 Polymerase Chain Reaction (PCR)
- 1.2.5 Other
- 1.3 Environmental Legionella Pneumophila Testing Market by Application
- 1.3.1 Global Environmental Legionella Pneumophila Testing Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Hospitals and Cinics
- 1.3.3 Diagnostic Laboratories
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Environmental Legionella Pneumophila Testing Market Dynamics
- 2.1 Environmental Legionella Pneumophila Testing Industry Trends
- 2.2 Environmental Legionella Pneumophila Testing Industry Drivers
- 2.3 Environmental Legionella Pneumophila Testing Industry Opportunities and Challenges
- 2.4 Environmental Legionella Pneumophila Testing Industry Restraints
3 Global Growth Perspective
- 3.1 Global Environmental Legionella Pneumophila Testing Market Perspective (2021-2032)
- 3.2 Global Environmental Legionella Pneumophila Testing Growth Trends by Region
- 3.2.1 Global Environmental Legionella Pneumophila Testing Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Environmental Legionella Pneumophila Testing Market Size by Region (2021-2026)
- 3.2.3 Global Environmental Legionella Pneumophila Testing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Environmental Legionella Pneumophila Testing Revenue by Players
- 4.1.1 Global Environmental Legionella Pneumophila Testing Revenue by Players (2021-2026)
- 4.1.2 Global Environmental Legionella Pneumophila Testing Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Environmental Legionella Pneumophila Testing Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Environmental Legionella Pneumophila Testing Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Environmental Legionella Pneumophila Testing Key Players Headquarters & Area Served
- 4.4 Global Environmental Legionella Pneumophila Testing Players, Product Type & Application
- 4.5 Global Environmental Legionella Pneumophila Testing Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Environmental Legionella Pneumophila Testing Market CR5 and HHI
- 4.6.3 2025 Environmental Legionella Pneumophila Testing Tier 1, Tier 2, and Tier 3
5 Environmental Legionella Pneumophila Testing Market Size by Type
- 5.1 Global Environmental Legionella Pneumophila Testing Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Environmental Legionella Pneumophila Testing Revenue by Type (2021-2032)
- 5.3 Global Environmental Legionella Pneumophila Testing Revenue Market Share by Type (2021-2032)
6 Environmental Legionella Pneumophila Testing Market Size by Application
- 6.1 Global Environmental Legionella Pneumophila Testing Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Environmental Legionella Pneumophila Testing Revenue by Application (2021-2032)
- 6.3 Global Environmental Legionella Pneumophila Testing Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Abbott Laboratories
- 7.1.1 Abbott Laboratories Company Information
- 7.1.2 Abbott Laboratories Business Overview
- 7.1.3 Abbott Laboratories Environmental Legionella Pneumophila Testing Revenue and Gross Margin (2021-2026)
- 7.1.4 Abbott Laboratories Environmental Legionella Pneumophila Testing Product Portfolio
- 7.1.5 Abbott Laboratories Recent Developments
- 7.2 AEMTEK
- 7.2.1 AEMTEK Company Information
- 7.2.2 AEMTEK Business Overview
- 7.2.3 AEMTEK Environmental Legionella Pneumophila Testing Revenue and Gross Margin (2021-2026)
- 7.2.4 AEMTEK Environmental Legionella Pneumophila Testing Product Portfolio
- 7.2.5 AEMTEK Recent Developments
- 7.3 ALS Environmental
- 7.3.1 ALS Environmental Company Information
- 7.3.2 ALS Environmental Business Overview
- 7.3.3 ALS Environmental Environmental Legionella Pneumophila Testing Revenue and Gross Margin (2021-2026)
- 7.3.4 ALS Environmental Environmental Legionella Pneumophila Testing Product Portfolio
- 7.3.5 ALS Environmental Recent Developments
- 7.4 BD
- 7.4.1 BD Company Information
- 7.4.2 BD Business Overview
- 7.4.3 BD Environmental Legionella Pneumophila Testing Revenue and Gross Margin (2021-2026)
- 7.4.4 BD Environmental Legionella Pneumophila Testing Product Portfolio
- 7.4.5 BD Recent Developments
- 7.5 BioMérieux
- 7.5.1 BioMérieux Company Information
- 7.5.2 BioMérieux Business Overview
- 7.5.3 BioMérieux Environmental Legionella Pneumophila Testing Revenue and Gross Margin (2021-2026)
- 7.5.4 BioMérieux Environmental Legionella Pneumophila Testing Product Portfolio
- 7.5.5 BioMérieux Recent Developments
- 7.6 Bio-Rad Laboratories
- 7.6.1 Bio-Rad Laboratories Company Information
- 7.6.2 Bio-Rad Laboratories Business Overview
- 7.6.3 Bio-Rad Laboratories Environmental Legionella Pneumophila Testing Revenue and Gross Margin (2021-2026)
- 7.6.4 Bio-Rad Laboratories Environmental Legionella Pneumophila Testing Product Portfolio
- 7.6.5 Bio-Rad Laboratories Recent Developments
- 7.7 Eiken Chemical
- 7.7.1 Eiken Chemical Company Information
- 7.7.2 Eiken Chemical Business Overview
- 7.7.3 Eiken Chemical Environmental Legionella Pneumophila Testing Revenue and Gross Margin (2021-2026)
- 7.7.4 Eiken Chemical Environmental Legionella Pneumophila Testing Product Portfolio
- 7.7.5 Eiken Chemical Recent Developments
- 7.8 Eurofins Scientific
- 7.8.1 Eurofins Scientific Company Information
- 7.8.2 Eurofins Scientific Business Overview
- 7.8.3 Eurofins Scientific Environmental Legionella Pneumophila Testing Revenue and Gross Margin (2021-2026)
- 7.8.4 Eurofins Scientific Environmental Legionella Pneumophila Testing Product Portfolio
- 7.8.5 Eurofins Scientific Recent Developments
- 7.9 HP Environmental
- 7.9.1 HP Environmental Company Information
- 7.9.2 HP Environmental Business Overview
- 7.9.3 HP Environmental Environmental Legionella Pneumophila Testing Revenue and Gross Margin (2021-2026)
- 7.9.4 HP Environmental Environmental Legionella Pneumophila Testing Product Portfolio
- 7.9.5 HP Environmental Recent Developments
- 7.10 Intertek
- 7.10.1 Intertek Company Information
- 7.10.2 Intertek Business Overview
- 7.10.3 Intertek Environmental Legionella Pneumophila Testing Revenue and Gross Margin (2021-2026)
- 7.10.4 Intertek Environmental Legionella Pneumophila Testing Product Portfolio
- 7.10.5 Intertek Recent Developments
- 7.11 Merck KGaA
- 7.11.1 Merck KGaA Company Information
- 7.11.2 Merck KGaA Business Overview
- 7.11.3 Merck KGaA Environmental Legionella Pneumophila Testing Revenue and Gross Margin (2021-2026)
- 7.11.4 Merck KGaA Environmental Legionella Pneumophila Testing Product Portfolio
- 7.11.5 Merck KGaA Recent Developments
- 7.12 Nova Biologicals
- 7.12.1 Nova Biologicals Company Information
- 7.12.2 Nova Biologicals Business Overview
- 7.12.3 Nova Biologicals Environmental Legionella Pneumophila Testing Revenue and Gross Margin (2021-2026)
- 7.12.4 Nova Biologicals Environmental Legionella Pneumophila Testing Product Portfolio
- 7.12.5 Nova Biologicals Recent Developments
- 7.13 QuidelOrtho
- 7.13.1 QuidelOrtho Company Information
- 7.13.2 QuidelOrtho Business Overview
- 7.13.3 QuidelOrtho Environmental Legionella Pneumophila Testing Revenue and Gross Margin (2021-2026)
- 7.13.4 QuidelOrtho Environmental Legionella Pneumophila Testing Product Portfolio
- 7.13.5 QuidelOrtho Recent Developments
- 7.14 SGS S.A.
- 7.14.1 SGS S.A. Company Information
- 7.14.2 SGS S.A. Business Overview
- 7.14.3 SGS S.A. Environmental Legionella Pneumophila Testing Revenue and Gross Margin (2021-2026)
- 7.14.4 SGS S.A. Environmental Legionella Pneumophila Testing Product Portfolio
- 7.14.5 SGS S.A. Recent Developments
- 7.15 TÜV Nord
- 7.15.1 TÜV Nord Company Information
- 7.15.2 TÜV Nord Business Overview
- 7.15.3 TÜV Nord Environmental Legionella Pneumophila Testing Revenue and Gross Margin (2021-2026)
- 7.15.4 TÜV Nord Environmental Legionella Pneumophila Testing Product Portfolio
- 7.15.5 TÜV Nord Recent Developments
- 7.16 Thermo Fisher Scientific
- 7.16.1 Thermo Fisher Scientific Company Information
- 7.16.2 Thermo Fisher Scientific Business Overview
- 7.16.3 Thermo Fisher Scientific Environmental Legionella Pneumophila Testing Revenue and Gross Margin (2021-2026)
- 7.16.4 Thermo Fisher Scientific Environmental Legionella Pneumophila Testing Product Portfolio
- 7.16.5 Thermo Fisher Scientific Recent Developments
8 North America
- 8.1 North America Environmental Legionella Pneumophila Testing Revenue (2021-2032)
- 8.2 North America Environmental Legionella Pneumophila Testing Revenue by Type (2021-2032)
- 8.2.1 North America Environmental Legionella Pneumophila Testing Revenue by Type (2021-2026)
- 8.2.2 North America Environmental Legionella Pneumophila Testing Revenue by Type (2027-2032)
- 8.3 North America Environmental Legionella Pneumophila Testing Revenue Share by Type (2021-2032)
- 8.4 North America Environmental Legionella Pneumophila Testing Revenue by Application (2021-2032)
- 8.4.1 North America Environmental Legionella Pneumophila Testing Revenue by Application (2021-2026)
- 8.4.2 North America Environmental Legionella Pneumophila Testing Revenue by Application (2027-2032)
- 8.5 North America Environmental Legionella Pneumophila Testing Revenue Share by Application (2021-2032)
- 8.6 North America Environmental Legionella Pneumophila Testing Revenue by Country
- 8.6.1 North America Environmental Legionella Pneumophila Testing Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Environmental Legionella Pneumophila Testing Revenue by Country (2021-2026)
- 8.6.3 North America Environmental Legionella Pneumophila Testing Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Environmental Legionella Pneumophila Testing Revenue (2021-2032)
- 9.2 Europe Environmental Legionella Pneumophila Testing Revenue by Type (2021-2032)
- 9.2.1 Europe Environmental Legionella Pneumophila Testing Revenue by Type (2021-2026)
- 9.2.2 Europe Environmental Legionella Pneumophila Testing Revenue by Type (2027-2032)
- 9.3 Europe Environmental Legionella Pneumophila Testing Revenue Share by Type (2021-2032)
- 9.4 Europe Environmental Legionella Pneumophila Testing Revenue by Application (2021-2032)
- 9.4.1 Europe Environmental Legionella Pneumophila Testing Revenue by Application (2021-2026)
- 9.4.2 Europe Environmental Legionella Pneumophila Testing Revenue by Application (2027-2032)
- 9.5 Europe Environmental Legionella Pneumophila Testing Revenue Share by Application (2021-2032)
- 9.6 Europe Environmental Legionella Pneumophila Testing Revenue by Country
- 9.6.1 Europe Environmental Legionella Pneumophila Testing Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Environmental Legionella Pneumophila Testing Revenue by Country (2021-2026)
- 9.6.3 Europe Environmental Legionella Pneumophila Testing Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Environmental Legionella Pneumophila Testing Revenue (2021-2032)
- 10.2 China Environmental Legionella Pneumophila Testing Revenue by Type (2021-2032)
- 10.2.1 China Environmental Legionella Pneumophila Testing Revenue by Type (2021-2026)
- 10.2.2 China Environmental Legionella Pneumophila Testing Revenue by Type (2027-2032)
- 10.3 China Environmental Legionella Pneumophila Testing Revenue Share by Type (2021-2032)
- 10.4 China Environmental Legionella Pneumophila Testing Revenue by Application (2021-2032)
- 10.4.1 China Environmental Legionella Pneumophila Testing Revenue by Application (2021-2026)
- 10.4.2 China Environmental Legionella Pneumophila Testing Revenue by Application (2027-2032)
- 10.5 China Environmental Legionella Pneumophila Testing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Environmental Legionella Pneumophila Testing Revenue (2021-2032)
- 11.2 Asia Environmental Legionella Pneumophila Testing Revenue by Type (2021-2032)
- 11.2.1 Asia Environmental Legionella Pneumophila Testing Revenue by Type (2021-2026)
- 11.2.2 Asia Environmental Legionella Pneumophila Testing Revenue by Type (2027-2032)
- 11.3 Asia Environmental Legionella Pneumophila Testing Revenue Share by Type (2021-2032)
- 11.4 Asia Environmental Legionella Pneumophila Testing Revenue by Application (2021-2032)
- 11.4.1 Asia Environmental Legionella Pneumophila Testing Revenue by Application (2021-2026)
- 11.4.2 Asia Environmental Legionella Pneumophila Testing Revenue by Application (2027-2032)
- 11.5 Asia Environmental Legionella Pneumophila Testing Revenue Share by Application (2021-2032)
- 11.6 Asia Environmental Legionella Pneumophila Testing Revenue by Country
- 11.6.1 Asia Environmental Legionella Pneumophila Testing Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Environmental Legionella Pneumophila Testing Revenue by Country (2021-2026)
- 11.6.3 Asia Environmental Legionella Pneumophila Testing Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Environmental Legionella Pneumophila Testing Revenue (2021-2032)
- 12.2 SAMEA Environmental Legionella Pneumophila Testing Revenue by Type (2021-2032)
- 12.2.1 SAMEA Environmental Legionella Pneumophila Testing Revenue by Type (2021-2026)
- 12.2.2 SAMEA Environmental Legionella Pneumophila Testing Revenue by Type (2027-2032)
- 12.3 SAMEA Environmental Legionella Pneumophila Testing Revenue Share by Type (2021-2032)
- 12.4 SAMEA Environmental Legionella Pneumophila Testing Revenue by Application (2021-2032)
- 12.4.1 SAMEA Environmental Legionella Pneumophila Testing Revenue by Application (2021-2026)
- 12.4.2 SAMEA Environmental Legionella Pneumophila Testing Revenue by Application (2027-2032)
- 12.5 SAMEA Environmental Legionella Pneumophila Testing Revenue Share by Application (2021-2032)
- 12.6 SAMEA Environmental Legionella Pneumophila Testing Revenue by Country
- 12.6.1 SAMEA Environmental Legionella Pneumophila Testing Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Environmental Legionella Pneumophila Testing Revenue by Country (2021-2026)
- 12.6.3 SAMEA Environmental Legionella Pneumophila Testing Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst